First Once-Weekly Basal Insulin Approved for Type 2 Diabetes
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — The FDA has approved icodec insulin (Awiqli) as the first long-acting once-weekly basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. It should be noted that the agency rejected the product in…
:max_bytes(150000):strip_icc()/Health-GettyImages-1162246366-ddd9cf28409e4a978570844579e15fc2.jpg?w=390&resize=390,220&ssl=1 "The Link Between IBD and Early-Onset Arthritis")
